Theravance Biopharma, Inc.TBPHNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Scaling
Trending higher, above historical average, structural decline.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-46.95M
↑ 75% above average
Average (9y)
$-186.35M
Historical baseline
Range
High:$-46.95M
Low:$-297.63M
CAGR
-14.0%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | $-46.95M | +16.2% |
| 2023 | $-56.03M | +39.1% |
| 2022 | $-91.96M | +64.3% |
| 2021 | $-257.78M | +13.4% |
| 2020 | $-297.63M | -18.1% |
| 2019 | $-251.91M | -5.5% |
| 2018 | $-238.75M | +8.2% |
| 2017 | $-260.12M | -44.1% |
| 2016 | $-180.47M | +0.8% |
| 2015 | $-181.90M | - |